 Ryan Bachtell
Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 22 | 2023 | 162 | 5.080 |
Why?
| | Drug-Seeking Behavior | 7 | 2023 | 22 | 3.370 |
Why?
| | Cocaine-Related Disorders | 14 | 2023 | 133 | 3.200 |
Why?
| | Central Nervous System Stimulants | 8 | 2023 | 185 | 2.280 |
Why?
| | Nucleus Accumbens | 13 | 2019 | 135 | 2.240 |
Why?
| | Methamphetamine | 5 | 2023 | 74 | 2.220 |
Why?
| | Receptor, Adenosine A2A | 6 | 2018 | 23 | 2.130 |
Why?
| | Conditioning, Operant | 10 | 2017 | 94 | 1.940 |
Why?
| | Self Administration | 26 | 2026 | 122 | 1.840 |
Why?
| | Dopamine Uptake Inhibitors | 9 | 2016 | 59 | 1.690 |
Why?
| | Receptors, Dopamine D2 | 6 | 2018 | 93 | 1.470 |
Why?
| | Toll-Like Receptor 4 | 6 | 2023 | 276 | 1.440 |
Why?
| | Dopamine Agonists | 9 | 2018 | 41 | 1.440 |
Why?
| | Receptor, Adenosine A1 | 4 | 2014 | 11 | 1.330 |
Why?
| | Rats | 32 | 2026 | 5585 | 1.310 |
Why?
| | Extinction, Psychological | 9 | 2023 | 92 | 1.210 |
Why?
| | Rats, Sprague-Dawley | 24 | 2023 | 2525 | 1.110 |
Why?
| | Ethanol | 12 | 2016 | 631 | 1.100 |
Why?
| | Behavior, Animal | 13 | 2016 | 520 | 1.060 |
Why?
| | Caffeine | 3 | 2018 | 74 | 1.000 |
Why?
| | Adenosine A2 Receptor Agonists | 5 | 2018 | 23 | 0.930 |
Why?
| | Receptors, AMPA | 5 | 2013 | 147 | 0.930 |
Why?
| | Central Nervous System Depressants | 5 | 2016 | 84 | 0.850 |
Why?
| | Ventral Tegmental Area | 5 | 2019 | 63 | 0.830 |
Why?
| | Dose-Response Relationship, Drug | 14 | 2023 | 2028 | 0.820 |
Why?
| | Behavior, Addictive | 3 | 2017 | 88 | 0.810 |
Why?
| | Analgesia | 1 | 2024 | 106 | 0.760 |
Why?
| | Locomotion | 3 | 2018 | 101 | 0.710 |
Why?
| | Alcohol Drinking | 6 | 2016 | 843 | 0.680 |
Why?
| | Adenosine A2 Receptor Antagonists | 2 | 2018 | 14 | 0.670 |
Why?
| | Proto-Oncogene Proteins c-fos | 10 | 2008 | 196 | 0.630 |
Why?
| | Animals | 45 | 2026 | 38106 | 0.620 |
Why?
| | Brain | 11 | 2023 | 2969 | 0.610 |
Why?
| | Reward | 5 | 2016 | 248 | 0.610 |
Why?
| | Corticotropin-Releasing Hormone | 6 | 2016 | 72 | 0.610 |
Why?
| | Neuroglia | 3 | 2017 | 174 | 0.600 |
Why?
| | Analgesics, Opioid | 5 | 2026 | 1154 | 0.590 |
Why?
| | Receptors, Dopamine D1 | 4 | 2013 | 34 | 0.570 |
Why?
| | Opioid-Related Disorders | 2 | 2024 | 605 | 0.560 |
Why?
| | Receptors, Purinergic P1 | 2 | 2023 | 30 | 0.560 |
Why?
| | Quinpirole | 5 | 2014 | 10 | 0.490 |
Why?
| | Substance-Related Disorders | 3 | 2017 | 1103 | 0.490 |
Why?
| | Adenosine | 6 | 2014 | 255 | 0.490 |
Why?
| | Motor Activity | 9 | 2018 | 718 | 0.480 |
Why?
| | Phenethylamines | 5 | 2014 | 16 | 0.460 |
Why?
| | Microglia | 2 | 2019 | 273 | 0.460 |
Why?
| | Encephalitis | 1 | 2017 | 142 | 0.450 |
Why?
| | Astrocytes | 1 | 2017 | 228 | 0.450 |
Why?
| | Xenobiotics | 1 | 2015 | 30 | 0.430 |
Why?
| | Oxycodone | 2 | 2026 | 52 | 0.430 |
Why?
| | Pituitary-Adrenal System | 1 | 2016 | 164 | 0.420 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2016 | 199 | 0.410 |
Why?
| | Dopamine | 6 | 2019 | 295 | 0.410 |
Why?
| | Genes, fos | 2 | 2003 | 36 | 0.370 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2011 | 185 | 0.370 |
Why?
| | Male | 39 | 2026 | 73012 | 0.360 |
Why?
| | Immunity, Innate | 1 | 2017 | 835 | 0.340 |
Why?
| | Sucrose | 6 | 2016 | 114 | 0.320 |
Why?
| | Gene Expression Regulation | 5 | 2016 | 2601 | 0.300 |
Why?
| | Naltrexone | 2 | 2023 | 115 | 0.270 |
Why?
| | Anxiety | 1 | 2016 | 1122 | 0.270 |
Why?
| | Gastrointestinal Microbiome | 2 | 2026 | 768 | 0.250 |
Why?
| | Septum of Brain | 2 | 2003 | 4 | 0.240 |
Why?
| | Cues | 2 | 2023 | 329 | 0.240 |
Why?
| | Genetic Background | 1 | 2026 | 16 | 0.240 |
Why?
| | Neural Pathways | 3 | 2008 | 317 | 0.240 |
Why?
| | Dopamine Antagonists | 1 | 2005 | 26 | 0.230 |
Why?
| | Pyrimidines | 3 | 2014 | 530 | 0.220 |
Why?
| | Aging | 1 | 2016 | 1973 | 0.220 |
Why?
| | Tegmentum Mesencephali | 1 | 2004 | 5 | 0.210 |
Why?
| | Purinergic P1 Receptor Agonists | 2 | 2014 | 7 | 0.210 |
Why?
| | Adenosine A1 Receptor Agonists | 2 | 2014 | 2 | 0.200 |
Why?
| | Hypothermia, Induced | 1 | 2004 | 96 | 0.190 |
Why?
| | Microinjections | 2 | 2013 | 92 | 0.190 |
Why?
| | Drinking Behavior | 2 | 2016 | 15 | 0.180 |
Why?
| | Alcoholism | 3 | 2003 | 826 | 0.170 |
Why?
| | Urocortins | 5 | 2004 | 24 | 0.170 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2013 | 42 | 0.170 |
Why?
| | Hypothermia | 1 | 2002 | 53 | 0.170 |
Why?
| | Narcotic Antagonists | 4 | 2019 | 203 | 0.170 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2013 | 108 | 0.160 |
Why?
| | Immediate-Early Proteins | 1 | 2001 | 46 | 0.160 |
Why?
| | Signal Transduction | 6 | 2019 | 5226 | 0.160 |
Why?
| | Drug Interactions | 3 | 2013 | 405 | 0.160 |
Why?
| | Mice, Inbred C57BL | 9 | 2004 | 5995 | 0.150 |
Why?
| | Benzazepines | 2 | 2013 | 35 | 0.150 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 858 | 0.150 |
Why?
| | Nerve Net | 1 | 2003 | 286 | 0.150 |
Why?
| | Lymphocyte Antigen 96 | 1 | 2019 | 23 | 0.150 |
Why?
| | Pyrazoles | 2 | 2014 | 517 | 0.150 |
Why?
| | Food Preferences | 2 | 2014 | 126 | 0.150 |
Why?
| | Stress, Psychological | 2 | 2018 | 1151 | 0.140 |
Why?
| | Amygdala | 2 | 2016 | 200 | 0.140 |
Why?
| | Immunohistochemistry | 6 | 2008 | 1723 | 0.140 |
Why?
| | Cell Count | 3 | 2004 | 319 | 0.140 |
Why?
| | Dorsal Raphe Nucleus | 1 | 2018 | 31 | 0.140 |
Why?
| | Serotonergic Neurons | 1 | 2018 | 29 | 0.140 |
Why?
| | Reinforcement Schedule | 2 | 2016 | 25 | 0.140 |
Why?
| | Transcription Factors | 3 | 2001 | 1736 | 0.140 |
Why?
| | Nicotine | 1 | 2001 | 331 | 0.130 |
Why?
| | Interleukin-1beta | 2 | 2017 | 390 | 0.130 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 2 | 2015 | 59 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 180 | 0.130 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2008 | 154 | 0.120 |
Why?
| | Mice | 13 | 2015 | 18358 | 0.120 |
Why?
| | TRPC Cation Channels | 1 | 2016 | 14 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 730 | 0.120 |
Why?
| | Paraventricular Hypothalamic Nucleus | 1 | 2016 | 34 | 0.120 |
Why?
| | Gene Transfer Techniques | 3 | 2013 | 187 | 0.120 |
Why?
| | Neurons | 5 | 2015 | 1652 | 0.110 |
Why?
| | Phosphorylation | 4 | 2013 | 1708 | 0.110 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 305 | 0.110 |
Why?
| | Analysis of Variance | 4 | 2012 | 1300 | 0.110 |
Why?
| | Brain Chemistry | 2 | 2008 | 120 | 0.110 |
Why?
| | Dopaminergic Neurons | 1 | 2016 | 68 | 0.110 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2016 | 147 | 0.110 |
Why?
| | Receptors, Adenosine A2 | 1 | 2014 | 5 | 0.110 |
Why?
| | Corticosterone | 1 | 2016 | 241 | 0.110 |
Why?
| | RNA, Messenger | 3 | 2017 | 2805 | 0.100 |
Why?
| | 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2013 | 6 | 0.100 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2013 | 15 | 0.100 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1482 | 0.100 |
Why?
| | Gene Expression | 2 | 2018 | 1478 | 0.090 |
Why?
| | Adenosine Deaminase Inhibitors | 1 | 2012 | 2 | 0.090 |
Why?
| | Adenosine Kinase | 1 | 2012 | 2 | 0.090 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 174 | 0.090 |
Why?
| | Stimulation, Chemical | 1 | 2012 | 52 | 0.090 |
Why?
| | Central Nervous System | 1 | 2015 | 282 | 0.090 |
Why?
| | Mice, Inbred DBA | 2 | 2003 | 182 | 0.090 |
Why?
| | Hippocampus | 3 | 2003 | 973 | 0.090 |
Why?
| | Purinergic P2X Receptor Antagonists | 1 | 2011 | 7 | 0.090 |
Why?
| | Adenosine Deaminase | 1 | 2012 | 43 | 0.090 |
Why?
| | Xanthines | 1 | 2011 | 23 | 0.090 |
Why?
| | Morpholines | 1 | 2012 | 130 | 0.090 |
Why?
| | Receptor, trkB | 2 | 2008 | 39 | 0.090 |
Why?
| | Sweetening Agents | 1 | 2011 | 57 | 0.080 |
Why?
| | Age Factors | 2 | 2018 | 3346 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2011 | 4568 | 0.080 |
Why?
| | Neostriatum | 1 | 2011 | 37 | 0.080 |
Why?
| | Tissue Distribution | 2 | 2002 | 335 | 0.080 |
Why?
| | Recurrence | 1 | 2014 | 1139 | 0.080 |
Why?
| | Association Learning | 1 | 2011 | 70 | 0.080 |
Why?
| | Naloxone | 3 | 2019 | 132 | 0.080 |
Why?
| | Genetic Vectors | 2 | 2008 | 335 | 0.080 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2016 | 72 | 0.080 |
Why?
| | Social Environment | 1 | 2011 | 252 | 0.070 |
Why?
| | MAP Kinase Signaling System | 1 | 2011 | 308 | 0.070 |
Why?
| | Presynaptic Terminals | 1 | 2008 | 89 | 0.070 |
Why?
| | Drug Tolerance | 1 | 2007 | 99 | 0.060 |
Why?
| | Impulsive Behavior | 1 | 2008 | 145 | 0.060 |
Why?
| | Glutamic Acid | 1 | 2008 | 255 | 0.060 |
Why?
| | Anesthetics, Local | 1 | 2007 | 104 | 0.060 |
Why?
| | Synaptic Transmission | 1 | 2008 | 292 | 0.060 |
Why?
| | Frontal Lobe | 1 | 2007 | 160 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2007 | 208 | 0.060 |
Why?
| | Cecum | 1 | 2026 | 37 | 0.060 |
Why?
| | Salicylamides | 1 | 2005 | 3 | 0.060 |
Why?
| | Morphine | 2 | 2008 | 169 | 0.060 |
Why?
| | Tetrahydronaphthalenes | 1 | 2005 | 34 | 0.060 |
Why?
| | Humans | 7 | 2023 | 145785 | 0.060 |
Why?
| | Prefrontal Cortex | 1 | 2008 | 336 | 0.050 |
Why?
| | Quinine | 1 | 2004 | 20 | 0.050 |
Why?
| | Pupil | 1 | 2004 | 22 | 0.050 |
Why?
| | Female | 5 | 2026 | 79045 | 0.050 |
Why?
| | Body Temperature | 1 | 2004 | 227 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2007 | 544 | 0.050 |
Why?
| | Brain Diseases | 1 | 2004 | 155 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2003 | 123 | 0.050 |
Why?
| | Aminoacetonitrile | 1 | 2002 | 1 | 0.050 |
Why?
| | Chlordiazepoxide | 1 | 2002 | 1 | 0.050 |
Why?
| | Feces | 1 | 2026 | 496 | 0.050 |
Why?
| | Yohimbine | 1 | 2002 | 11 | 0.050 |
Why?
| | Mesencephalon | 1 | 2002 | 65 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2003 | 396 | 0.050 |
Why?
| | Haloperidol | 1 | 2002 | 32 | 0.050 |
Why?
| | Down-Regulation | 2 | 2018 | 618 | 0.040 |
Why?
| | Pregnanolone | 1 | 2002 | 34 | 0.040 |
Why?
| | Time Factors | 3 | 2012 | 7134 | 0.040 |
Why?
| | Protease Inhibitors | 1 | 2002 | 102 | 0.040 |
Why?
| | Body Temperature Regulation | 1 | 2003 | 105 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2003 | 507 | 0.040 |
Why?
| | Norepinephrine | 1 | 2002 | 201 | 0.040 |
Why?
| | Cold Temperature | 1 | 2003 | 206 | 0.040 |
Why?
| | Early Growth Response Protein 1 | 1 | 2001 | 32 | 0.040 |
Why?
| | Pentobarbital | 1 | 2000 | 17 | 0.040 |
Why?
| | Species Specificity | 1 | 2002 | 546 | 0.040 |
Why?
| | Exploratory Behavior | 1 | 2001 | 85 | 0.040 |
Why?
| | Hot Temperature | 1 | 2003 | 396 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 633 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 782 | 0.040 |
Why?
| | Drug Combinations | 1 | 2001 | 396 | 0.040 |
Why?
| | Organic Cation Transport Proteins | 1 | 2018 | 25 | 0.040 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2018 | 37 | 0.040 |
Why?
| | Tryptophan Hydroxylase | 1 | 2018 | 54 | 0.030 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2018 | 62 | 0.030 |
Why?
| | Reaction Time | 2 | 2012 | 434 | 0.030 |
Why?
| | Child | 1 | 2018 | 22740 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 783 | 0.030 |
Why?
| | Rats, Long-Evans | 2 | 2008 | 128 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2001 | 474 | 0.030 |
Why?
| | Molecular Dynamics Simulation | 1 | 2019 | 265 | 0.030 |
Why?
| | Sex Factors | 1 | 2003 | 2110 | 0.030 |
Why?
| | Rats, Transgenic | 1 | 2016 | 20 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2002 | 789 | 0.030 |
Why?
| | Maze Learning | 1 | 2016 | 105 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2016 | 268 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 667 | 0.030 |
Why?
| | Membrane Potentials | 1 | 2016 | 278 | 0.030 |
Why?
| | Mice, Inbred C3H | 1 | 2015 | 254 | 0.030 |
Why?
| | Phenotype | 1 | 2003 | 3170 | 0.030 |
Why?
| | Drug Administration Routes | 1 | 2012 | 42 | 0.020 |
Why?
| | Microdialysis | 1 | 2012 | 56 | 0.020 |
Why?
| | Pain Threshold | 1 | 2012 | 72 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 172 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 119 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2012 | 127 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1261 | 0.020 |
Why?
| | Narcotics | 1 | 2008 | 58 | 0.020 |
Why?
| | Integrases | 1 | 2008 | 122 | 0.020 |
Why?
| | Adenoviridae | 1 | 2008 | 199 | 0.020 |
Why?
| | Synapsins | 1 | 2007 | 13 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1599 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4151 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2012 | 2192 | 0.020 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2007 | 70 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 165 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 125 | 0.010 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 146 | 0.010 |
Why?
| | Protein Binding | 1 | 2012 | 2240 | 0.010 |
Why?
| | Hallucinogens | 1 | 2008 | 111 | 0.010 |
Why?
| | Protein Kinase C | 1 | 2007 | 251 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 751 | 0.010 |
Why?
| | Dronabinol | 1 | 2008 | 249 | 0.010 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 229 | 0.010 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 196 | 0.010 |
Why?
| | Mutation | 1 | 2015 | 4090 | 0.010 |
Why?
| | Neurotransmitter Agents | 1 | 2003 | 84 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2007 | 1137 | 0.010 |
Why?
| | Hypothalamus | 1 | 2002 | 163 | 0.010 |
Why?
| | Genes, Immediate-Early | 1 | 2001 | 26 | 0.010 |
Why?
| | Choice Behavior | 1 | 2002 | 180 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1777 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2007 | 3130 | 0.010 |
Why?
| | Brain Mapping | 1 | 2003 | 542 | 0.010 |
Why?
| | Cognition | 1 | 2008 | 1271 | 0.010 |
Why?
| | Anesthetics | 1 | 2000 | 100 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2002 | 513 | 0.010 |
Why?
| | Stress, Physiological | 1 | 2000 | 443 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 729 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2000 | 1166 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2000 | 968 | 0.010 |
Why?
|
|
Bachtell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|